COMPLETE PERFORMANCE
ORDER INFORMATION
SUPERIOR RADIAL FORCE WITHOUT SACRIFICING CONFORMABILITY*
SC 6 20 LG
5.0
5.46 4.61
8mm x 80 mm
8mm x 100 mm 5.16
5.13
Retractable sheath
5.08 4.55
4.15
4.0
3.60
Radiopaque markers
Stabilizing sheath
3.62 2.69
3.0
Stent Diameter (mm)
2.0 1.0 0.0 Medtronic Cordis Complete Smart® SE Control®
Bard LifeStent®
Medtronic Complete SE
Cook Zilver® 635
Bard LifeStent
Medtronic Complete SE
Cordis Smart Control
Abbott ev3 Absolute Protégé® Pro® EverFlex®
Testing was performed with a flat-plate crush to 30% of labeled nominal stent diameter.
OPTIMISED CELL DESIGN FOR KINK RESISTANCE AND FLEXIBILITY *
Stent Length (mm) 20
30
40
60
80
100
120
150
Catheter Minimum Working Sheath Length Size (F) (cm)
4
SC420LG
SC430LG
SC440LG
—
—
—
—
—
6
130
5
SC520LG
SC530LG
SC540LG
SC560LG
SC580LG
SC5100LG
SC5120LG
SC5150LG
6
130
6
SC620LG
—
SC640LG
SC660LG
SC680LG
SC6100LG
SC6120LG
SC6150LG
6
130
7
SC720LG
—
SC740LG
SC760LG
SC780LG
SC7100LG
SC7120LG
SC7150LG
6
130
8
SC820LG
—
SC840LG
SC860LG
SC880LG
SC8100LG
SC8120LG
SC8150LG
6
130
9
SC920LG
—
SC940LG
SC960LG
SC980LG
—
—
—
6
130
10
SC1020LG
—
SC1040LG
SC1060LG
SC1080LG
—
—
—
6
130
Stent Diameter (mm)
Stent Length (mm) 150
Catheter Minimum Working Sheath Length Size (F) (cm)
20
30
40
60
80
100
120
4
SC420FG
SC430FG
SC440FG
—
—
—
—
—
6
80
5
SC520FG
SC530FG
SC540FG
SC560FG
SC580FG
SC5100FG
SC5120FG
SC5150FG
6
80
6
SC620FG
—
SC640FG
SC660FG
SC680FG
SC6100FG
SC6120FG
SC6150FG
6
80
7
SC720FG
—
SC740FG
SC760FG
SC780FG
SC7100FG
SC7120FG
SC7150FG
6
80
8
SC820FG
—
SC840FG
SC860FG
SC880FG
SC8100FG
SC8120FG
SC8150FG
6
80
9
SC920FG
—
SC940FG
SC960FG
SC980FG
—
—
—
6
80
10
SC1020FG
—
SC1040FG
SC1060FG
SC1080FG
—
—
—
6
80
The Complete SE stent is MRI conditional. The Complete SE Vascular Self-Expanding Stent System is indicated to improve luminal diameter in symptomatic patients with previously unstented iliac stenosis in the common and external iliac arteries or atherosclerotic lesions of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (PPA) with vessel reference diameters between 3.5 mm and 9.0 mm. Warning: Please reference appropriate product Instructions for Use for a list of indications, warnings, precautions and potential adverse event
Offset crown design minimises crown-tocrown interaction while bending
NOW APPROVED For SFA/PPA
SELF-EXPANDING STENT SYSTEM
Dual-deployment handle
Three different segment lengths allow consistent behavior across all diameters: • M inimal foreshortening • E xcellent flexibility
* Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance.
Tested in multimode conditions representative of the iliac, superficial femoral and proximal popliteal arteries to substantiate long-term performance
www.medtronicendovascular.com www.medtronic.eu Invatec S.p.A. Via Martiri della Libertà 7 25030 Roncadelle (BS) Italy Tel: +39.030.2589311
INVATEC Technology Center GmbH Hungerbüelstrasse 12a 8500 Frauenfeld Switzerland Tel: +41.52.2600660
Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432 USA Tel: +1.763.514.4000
Medtronic International Trading Sàrl Route du Molliau 31 CH-1131 Tolochenaz Switzerland Tel: +41.21.802.7000
Medtronic of Canada Ltd. 99 Hereford Street Brampton, Ontario L6Y 0R3 Canada Tel: +1.905.460.3800
Medtronic Latin America 3750 NW 87th Avenue, Suite 700 Miami, FL 33178 USA Tel: +1.786.709.4200
Medtronic International Ltd. 49 Changi South Avenue 2 Singapore 486056 Tel: +65.6436.5000
Medtronic Australasia Pty Ltd. 97 Waterloo Road North Ryde, NSW 2113 Australia Tel: +61.29857.9000
Medtronic Korea Co., Ltd. 5F, Sajo Building 1001 Daechi-dong, Kangnam-ku Seoul, 135-280 Korea Tel: +82.2.3404.3600
Medtronic Mediterranean S.A.L. St. Charles City Center 6th Floor, Omar Doauk Street Beirut 2020-0908 Lebanon Tel: +961.1.370670
UC201300554 EE © 2013 Medtronic, Inc. All rights reserved. Not for distribution in the USA . 01/13
Mean Radial Force (N)
6.0
Atraumatic tip
Catheter Working Length Length (F = 80, L = 130) Diameter Product Code
RADIAL FORCE 7mm x 100 mm
Complete SE Vascular ™
Complete™ SE Vascular Product Code
Complete Performance CONTROL. COMMITMENT. CONFIDENCE.
Innovating for life.
COMPLETE CONTROL
COMPLETE COMMITMENT
COMPLETE CONFIDENCE
DEPLOYMENT AND ACCURACY MADE EASY
APPROVED FOR ILIAC ARTERY, SFA AND PPA
FEWEST REINTERVENTIONS IN THE SFA*
Medtronic and physicians alike are committed to improving patients’ lives. We pursue this mission, in part, by arming healthcare providers with clinical data they need to practice evidence-centered medicine. Complete® SE embodies this commitment with continued follow-up in clinical trials that capture the device’s safety and efficacy in the iliac, superficial femoral and proximal popliteal arteries.
An independently adjudicated single-arm multicenter trial evaluated the performance of Complete® SE for the treatment of atherosclerotic lesions of the superficial femoral and proximal popliteal arteries. A representative population comprised of 196 subjects was enrolled with results compared with VIVA Performance Goals.†
The Complete® SE 6 F delivery system’s unique design incorporates a dual deployment handle and a triaxial catheter. The dual deployment handle is intuitive and easy to use, giving you the ultimate control during deployment while the triaxial catheter minimises unexpected jumping.*
TLR rate
8.4% at 12 months††
PATIENT DEMOGRAPHICS N = 196
Dual Deployment Handle*
%
Age
68.7 ± 10.5
Male
63.3
Diabetes mellitus
45.4
Dyslipidemia
79.6
Hypertension
90.3
History of tobacco use
79.6
History of CAD
62.8
History of COPD
21.4
Previous MI
26.2
%
(m/n)3
Total lesion length (n = 213)2 (mm)
60.7
± 37.62
Total occlusion
29.9
(60/201)
Distal SFA/PPA
49.7
(106/213)
Mid SFA
34.3
(73/213)
Proximal SFA
16.0
(34/213)
Severe
56.2
(118/210)
Moderate
34.8
(73/210)
None/mild
9.0
(19/210)
LESION MORPHOLOGY1 1. R otate the handle to retract the sheath slowly and allow the stent to expand in a precisely controlled manner.†
Triaxial Catheter
2. O nce the stent is properly positioned, complete the deployment by simply pushing the buttons and pulling back the handle in one fluid motion.
ISIS-SE Study
12-month MAE TVR TLR The delivery system’s triaxial design includes an inner shaft, a retractable sheath and a stabilising sheath. Retractable sheath
Complete SE Iliac Registry 3.3% 2.1% 2.1%
(n = 158)
Complete SE SFA Study
9-month MAE TVR TLR
9.4% 9.4% 3.8%
(n = 55)
12-month MAE TVR TLR
(n = 196)
BINARY TRIAL ENDPOINT ††
2002
2005
2011
Inner shaft The stabilising sheath reduces friction and allows the retractable sheath to move back freely. This decreases the amount of force required to deploy the stent, making deployment easy and accurate. * Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance. † Data on file
Calcification
11.0% 11.0% 8.4%
%
MAE at 12 months
11.0
TVR
11.0
TLR
8.4
PRIMARY EFFICACY ENDPOINT * Compared with SFA studies of Cook Zilver PTX, IDEV SUPERA, Cordis Smart Stent, Bard Lifestent and EV3 Protégé Everflex. † Rocha-Singh K et al. Catheter Cardiovasc Interv. 2007;69:910-919. †† Reference Complete SE SFA Study - Clinically Driven TLR rate. 1 Independently adjudicated by core lab. 2 Lesions as reported by the Angiographic Core Laboratory. 3 Based on number of lesions with available data.
Primary patency (PSVR < 2.0)
72.6
COMPLETE CONTROL
COMPLETE COMMITMENT
COMPLETE CONFIDENCE
DEPLOYMENT AND ACCURACY MADE EASY
APPROVED FOR ILIAC ARTERY, SFA AND PPA
FEWEST REINTERVENTIONS IN THE SFA*
Medtronic and physicians alike are committed to improving patients’ lives. We pursue this mission, in part, by arming healthcare providers with clinical data they need to practice evidence-centered medicine. Complete® SE embodies this commitment with continued follow-up in clinical trials that capture the device’s safety and efficacy in the iliac, superficial femoral and proximal popliteal arteries.
An independently adjudicated single-arm multicenter trial evaluated the performance of Complete® SE for the treatment of atherosclerotic lesions of the superficial femoral and proximal popliteal arteries. A representative population comprised of 196 subjects was enrolled with results compared with VIVA Performance Goals.†
The Complete® SE 6 F delivery system’s unique design incorporates a dual deployment handle and a triaxial catheter. The dual deployment handle is intuitive and easy to use, giving you the ultimate control during deployment while the triaxial catheter minimises unexpected jumping.*
TLR rate
8.4% at 12 months††
PATIENT DEMOGRAPHICS N = 196
Dual Deployment Handle*
%
Age
68.7 ± 10.5
Male
63.3
Diabetes mellitus
45.4
Dyslipidemia
79.6
Hypertension
90.3
History of tobacco use
79.6
History of CAD
62.8
History of COPD
21.4
Previous MI
26.2
%
(m/n)3
Total lesion length (n = 213)2 (mm)
60.7
± 37.62
Total occlusion
29.9
(60/201)
Distal SFA/PPA
49.7
(106/213)
Mid SFA
34.3
(73/213)
Proximal SFA
16.0
(34/213)
Severe
56.2
(118/210)
Moderate
34.8
(73/210)
None/mild
9.0
(19/210)
LESION MORPHOLOGY1 1. R otate the handle to retract the sheath slowly and allow the stent to expand in a precisely controlled manner.†
Triaxial Catheter
2. O nce the stent is properly positioned, complete the deployment by simply pushing the buttons and pulling back the handle in one fluid motion.
ISIS-SE Study
12-month MAE TVR TLR The delivery system’s triaxial design includes an inner shaft, a retractable sheath and a stabilising sheath. Retractable sheath
Complete SE Iliac Registry 3.3% 2.1% 2.1%
(n = 158)
Complete SE SFA Study
9-month MAE TVR TLR
9.4% 9.4% 3.8%
(n = 55)
12-month MAE TVR TLR
(n = 196)
BINARY TRIAL ENDPOINT ††
2002
2005
2011
Inner shaft The stabilising sheath reduces friction and allows the retractable sheath to move back freely. This decreases the amount of force required to deploy the stent, making deployment easy and accurate. * Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance. † Data on file
Calcification
11.0% 11.0% 8.4%
%
MAE at 12 months
11.0
TVR
11.0
TLR
8.4
PRIMARY EFFICACY ENDPOINT * Compared with SFA studies of Cook Zilver PTX, IDEV SUPERA, Cordis Smart Stent, Bard Lifestent and EV3 Protégé Everflex. † Rocha-Singh K et al. Catheter Cardiovasc Interv. 2007;69:910-919. †† Reference Complete SE SFA Study - Clinically Driven TLR rate. 1 Independently adjudicated by core lab. 2 Lesions as reported by the Angiographic Core Laboratory. 3 Based on number of lesions with available data.
Primary patency (PSVR < 2.0)
72.6
COMPLETE CONTROL
COMPLETE COMMITMENT
COMPLETE CONFIDENCE
DEPLOYMENT AND ACCURACY MADE EASY
APPROVED FOR ILIAC ARTERY, SFA AND PPA
FEWEST REINTERVENTIONS IN THE SFA*
Medtronic and physicians alike are committed to improving patients’ lives. We pursue this mission, in part, by arming healthcare providers with clinical data they need to practice evidence-centered medicine. Complete® SE embodies this commitment with continued follow-up in clinical trials that capture the device’s safety and efficacy in the iliac, superficial femoral and proximal popliteal arteries.
An independently adjudicated single-arm multicenter trial evaluated the performance of Complete® SE for the treatment of atherosclerotic lesions of the superficial femoral and proximal popliteal arteries. A representative population comprised of 196 subjects was enrolled with results compared with VIVA Performance Goals.†
The Complete® SE 6 F delivery system’s unique design incorporates a dual deployment handle and a triaxial catheter. The dual deployment handle is intuitive and easy to use, giving you the ultimate control during deployment while the triaxial catheter minimises unexpected jumping.*
TLR rate
8.4% at 12 months††
PATIENT DEMOGRAPHICS N = 196
Dual Deployment Handle*
%
Age
68.7 ± 10.5
Male
63.3
Diabetes mellitus
45.4
Dyslipidemia
79.6
Hypertension
90.3
History of tobacco use
79.6
History of CAD
62.8
History of COPD
21.4
Previous MI
26.2
%
(m/n)3
Total lesion length (n = 213)2 (mm)
60.7
± 37.62
Total occlusion
29.9
(60/201)
Distal SFA/PPA
49.7
(106/213)
Mid SFA
34.3
(73/213)
Proximal SFA
16.0
(34/213)
Severe
56.2
(118/210)
Moderate
34.8
(73/210)
None/mild
9.0
(19/210)
LESION MORPHOLOGY1 1. R otate the handle to retract the sheath slowly and allow the stent to expand in a precisely controlled manner.†
Triaxial Catheter
2. O nce the stent is properly positioned, complete the deployment by simply pushing the buttons and pulling back the handle in one fluid motion.
ISIS-SE Study
12-month MAE TVR TLR The delivery system’s triaxial design includes an inner shaft, a retractable sheath and a stabilising sheath. Retractable sheath
Complete SE Iliac Registry 3.3% 2.1% 2.1%
(n = 158)
Complete SE SFA Study
9-month MAE TVR TLR
9.4% 9.4% 3.8%
(n = 55)
12-month MAE TVR TLR
(n = 196)
BINARY TRIAL ENDPOINT ††
2002
2005
2011
Inner shaft The stabilising sheath reduces friction and allows the retractable sheath to move back freely. This decreases the amount of force required to deploy the stent, making deployment easy and accurate. * Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance. † Data on file
Calcification
11.0% 11.0% 8.4%
%
MAE at 12 months
11.0
TVR
11.0
TLR
8.4
PRIMARY EFFICACY ENDPOINT * Compared with SFA studies of Cook Zilver PTX, IDEV SUPERA, Cordis Smart Stent, Bard Lifestent and EV3 Protégé Everflex. † Rocha-Singh K et al. Catheter Cardiovasc Interv. 2007;69:910-919. †† Reference Complete SE SFA Study - Clinically Driven TLR rate. 1 Independently adjudicated by core lab. 2 Lesions as reported by the Angiographic Core Laboratory. 3 Based on number of lesions with available data.
Primary patency (PSVR < 2.0)
72.6
COMPLETE PERFORMANCE
ORDER INFORMATION
SUPERIOR RADIAL FORCE WITHOUT SACRIFICING CONFORMABILITY*
SC 6 20 LG
5.0
5.46 4.61
8mm x 80 mm
8mm x 100 mm 5.16
5.13
Retractable sheath
5.08 4.55
4.15
4.0
3.60
Radiopaque markers
Stabilizing sheath
3.62 2.69
3.0
Stent Diameter (mm)
2.0 1.0 0.0 Medtronic Cordis Complete Smart® SE Control®
Bard LifeStent®
Medtronic Complete SE
Cook Zilver® 635
Bard LifeStent
Medtronic Complete SE
Cordis Smart Control
Abbott ev3 Absolute Protégé® Pro® EverFlex®
Testing was performed with a flat-plate crush to 30% of labeled nominal stent diameter.
OPTIMISED CELL DESIGN FOR KINK RESISTANCE AND FLEXIBILITY *
Stent Length (mm) 20
30
40
60
80
100
120
150
Catheter Minimum Working Sheath Length Size (F) (cm)
4
SC420LG
SC430LG
SC440LG
—
—
—
—
—
6
130
5
SC520LG
SC530LG
SC540LG
SC560LG
SC580LG
SC5100LG
SC5120LG
SC5150LG
6
130
6
SC620LG
—
SC640LG
SC660LG
SC680LG
SC6100LG
SC6120LG
SC6150LG
6
130
7
SC720LG
—
SC740LG
SC760LG
SC780LG
SC7100LG
SC7120LG
SC7150LG
6
130
8
SC820LG
—
SC840LG
SC860LG
SC880LG
SC8100LG
SC8120LG
SC8150LG
6
130
9
SC920LG
—
SC940LG
SC960LG
SC980LG
—
—
—
6
130
10
SC1020LG
—
SC1040LG
SC1060LG
SC1080LG
—
—
—
6
130
Stent Diameter (mm)
Stent Length (mm) 150
Catheter Minimum Working Sheath Length Size (F) (cm)
20
30
40
60
80
100
120
4
SC420FG
SC430FG
SC440FG
—
—
—
—
—
6
80
5
SC520FG
SC530FG
SC540FG
SC560FG
SC580FG
SC5100FG
SC5120FG
SC5150FG
6
80
6
SC620FG
—
SC640FG
SC660FG
SC680FG
SC6100FG
SC6120FG
SC6150FG
6
80
7
SC720FG
—
SC740FG
SC760FG
SC780FG
SC7100FG
SC7120FG
SC7150FG
6
80
8
SC820FG
—
SC840FG
SC860FG
SC880FG
SC8100FG
SC8120FG
SC8150FG
6
80
9
SC920FG
—
SC940FG
SC960FG
SC980FG
—
—
—
6
80
10
SC1020FG
—
SC1040FG
SC1060FG
SC1080FG
—
—
—
6
80
The Complete SE stent is MRI conditional. The Complete SE Vascular Self-Expanding Stent System is indicated to improve luminal diameter in symptomatic patients with previously unstented iliac stenosis in the common and external iliac arteries or atherosclerotic lesions of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (PPA) with vessel reference diameters between 3.5 mm and 9.0 mm. Warning: Please reference appropriate product Instructions for Use for a list of indications, warnings, precautions and potential adverse event
Offset crown design minimises crown-tocrown interaction while bending
NOW APPROVED For SFA/PPA
SELF-EXPANDING STENT SYSTEM
Dual-deployment handle
Three different segment lengths allow consistent behavior across all diameters: • M inimal foreshortening • E xcellent flexibility
* Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance.
Tested in multimode conditions representative of the iliac, superficial femoral and proximal popliteal arteries to substantiate long-term performance
www.medtronicendovascular.com www.medtronic.eu Invatec S.p.A. Via Martiri della Libertà 7 25030 Roncadelle (BS) Italy Tel: +39.030.2589311
INVATEC Technology Center GmbH Hungerbüelstrasse 12a 8500 Frauenfeld Switzerland Tel: +41.52.2600660
Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432 USA Tel: +1.763.514.4000
Medtronic International Trading Sàrl Route du Molliau 31 CH-1131 Tolochenaz Switzerland Tel: +41.21.802.7000
Medtronic of Canada Ltd. 99 Hereford Street Brampton, Ontario L6Y 0R3 Canada Tel: +1.905.460.3800
Medtronic Latin America 3750 NW 87th Avenue, Suite 700 Miami, FL 33178 USA Tel: +1.786.709.4200
Medtronic International Ltd. 49 Changi South Avenue 2 Singapore 486056 Tel: +65.6436.5000
Medtronic Australasia Pty Ltd. 97 Waterloo Road North Ryde, NSW 2113 Australia Tel: +61.29857.9000
Medtronic Korea Co., Ltd. 5F, Sajo Building 1001 Daechi-dong, Kangnam-ku Seoul, 135-280 Korea Tel: +82.2.3404.3600
Medtronic Mediterranean S.A.L. St. Charles City Center 6th Floor, Omar Doauk Street Beirut 2020-0908 Lebanon Tel: +961.1.370670
UC201300554 EE © 2013 Medtronic, Inc. All rights reserved. Not for distribution in the USA . 01/13
Mean Radial Force (N)
6.0
Atraumatic tip
Catheter Working Length Length (F = 80, L = 130) Diameter Product Code
RADIAL FORCE 7mm x 100 mm
Complete SE Vascular ™
Complete™ SE Vascular Product Code
Complete Performance CONTROL. COMMITMENT. CONFIDENCE.
Innovating for life.
COMPLETE PERFORMANCE
ORDER INFORMATION
SUPERIOR RADIAL FORCE WITHOUT SACRIFICING CONFORMABILITY*
SC 6 20 LG
5.0
5.46 4.61
8mm x 80 mm
8mm x 100 mm 5.16
5.13
Retractable sheath
5.08 4.55
4.15
4.0
3.60
Radiopaque markers
Stabilizing sheath
3.62 2.69
3.0
Stent Diameter (mm)
2.0 1.0 0.0 Medtronic Cordis Complete Smart® SE Control®
Bard LifeStent®
Medtronic Complete SE
Cook Zilver® 635
Bard LifeStent
Medtronic Complete SE
Cordis Smart Control
Abbott ev3 Absolute Protégé® Pro® EverFlex®
Testing was performed with a flat-plate crush to 30% of labeled nominal stent diameter.
OPTIMISED CELL DESIGN FOR KINK RESISTANCE AND FLEXIBILITY *
Stent Length (mm) 20
30
40
60
80
100
120
150
Catheter Minimum Working Sheath Length Size (F) (cm)
4
SC420LG
SC430LG
SC440LG
—
—
—
—
—
6
130
5
SC520LG
SC530LG
SC540LG
SC560LG
SC580LG
SC5100LG
SC5120LG
SC5150LG
6
130
6
SC620LG
—
SC640LG
SC660LG
SC680LG
SC6100LG
SC6120LG
SC6150LG
6
130
7
SC720LG
—
SC740LG
SC760LG
SC780LG
SC7100LG
SC7120LG
SC7150LG
6
130
8
SC820LG
—
SC840LG
SC860LG
SC880LG
SC8100LG
SC8120LG
SC8150LG
6
130
9
SC920LG
—
SC940LG
SC960LG
SC980LG
—
—
—
6
130
10
SC1020LG
—
SC1040LG
SC1060LG
SC1080LG
—
—
—
6
130
Stent Diameter (mm)
Stent Length (mm) 150
Catheter Minimum Working Sheath Length Size (F) (cm)
20
30
40
60
80
100
120
4
SC420FG
SC430FG
SC440FG
—
—
—
—
—
6
80
5
SC520FG
SC530FG
SC540FG
SC560FG
SC580FG
SC5100FG
SC5120FG
SC5150FG
6
80
6
SC620FG
—
SC640FG
SC660FG
SC680FG
SC6100FG
SC6120FG
SC6150FG
6
80
7
SC720FG
—
SC740FG
SC760FG
SC780FG
SC7100FG
SC7120FG
SC7150FG
6
80
8
SC820FG
—
SC840FG
SC860FG
SC880FG
SC8100FG
SC8120FG
SC8150FG
6
80
9
SC920FG
—
SC940FG
SC960FG
SC980FG
—
—
—
6
80
10
SC1020FG
—
SC1040FG
SC1060FG
SC1080FG
—
—
—
6
80
The Complete SE stent is MRI conditional. The Complete SE Vascular Self-Expanding Stent System is indicated to improve luminal diameter in symptomatic patients with previously unstented iliac stenosis in the common and external iliac arteries or atherosclerotic lesions of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (PPA) with vessel reference diameters between 3.5 mm and 9.0 mm. Warning: Please reference appropriate product Instructions for Use for a list of indications, warnings, precautions and potential adverse event
Offset crown design minimises crown-tocrown interaction while bending
NOW APPROVED For SFA/PPA
SELF-EXPANDING STENT SYSTEM
Dual-deployment handle
Three different segment lengths allow consistent behavior across all diameters: • M inimal foreshortening • E xcellent flexibility
* Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance.
Tested in multimode conditions representative of the iliac, superficial femoral and proximal popliteal arteries to substantiate long-term performance
www.medtronicendovascular.com www.medtronic.eu Invatec S.p.A. Via Martiri della Libertà 7 25030 Roncadelle (BS) Italy Tel: +39.030.2589311
INVATEC Technology Center GmbH Hungerbüelstrasse 12a 8500 Frauenfeld Switzerland Tel: +41.52.2600660
Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432 USA Tel: +1.763.514.4000
Medtronic International Trading Sàrl Route du Molliau 31 CH-1131 Tolochenaz Switzerland Tel: +41.21.802.7000
Medtronic of Canada Ltd. 99 Hereford Street Brampton, Ontario L6Y 0R3 Canada Tel: +1.905.460.3800
Medtronic Latin America 3750 NW 87th Avenue, Suite 700 Miami, FL 33178 USA Tel: +1.786.709.4200
Medtronic International Ltd. 49 Changi South Avenue 2 Singapore 486056 Tel: +65.6436.5000
Medtronic Australasia Pty Ltd. 97 Waterloo Road North Ryde, NSW 2113 Australia Tel: +61.29857.9000
Medtronic Korea Co., Ltd. 5F, Sajo Building 1001 Daechi-dong, Kangnam-ku Seoul, 135-280 Korea Tel: +82.2.3404.3600
Medtronic Mediterranean S.A.L. St. Charles City Center 6th Floor, Omar Doauk Street Beirut 2020-0908 Lebanon Tel: +961.1.370670
UC201300554 EE © 2013 Medtronic, Inc. All rights reserved. Not for distribution in the USA . 01/13
Mean Radial Force (N)
6.0
Atraumatic tip
Catheter Working Length Length (F = 80, L = 130) Diameter Product Code
RADIAL FORCE 7mm x 100 mm
Complete SE Vascular ™
Complete™ SE Vascular Product Code
Complete Performance CONTROL. COMMITMENT. CONFIDENCE.
Innovating for life.